German-based BioNTech has announced that they will soon be joining Montgomery County, Maryland’s growing list of world-renowned international companies in the “Immunology Capital Next to the Nation’s Capital.” BioNTech is acquiring a Gaithersburg manufacturing facility and cell therapy R&D platform from Kite, a unit of Gilead Sciences, to support the development of BioNTech’s expanding pipeline of novel cell therapies.
{iframe}https://open.maryland.gov/blog/biontech-selects-maryland-us-manufacturing-facility/?utm_source=Maryland+Department+of+Commerce+%28MAIN+LIST%29&utm_campaign=027cfbdde5-Business_Pulse_08_27_20_COPY_01&utm_medium=email&utm_term=0_f78deb20ad-027cfbdde5-142072933{/iframe}